Covered recipient · General Payments record
ROBERTO A LEON FERRE
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2021–2024
$21,350.60
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,355.00 | 4 |
| Food and Beverage | $305.75 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $3,000.00 | 4 |
| Merck Sharp & Dohme Corporation | $2,135.00 | 1 |
| Gilead Sciences, Inc. | $525.75 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $135.00 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105619663 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,370.00 | 07/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104475482 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105361627 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,370.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105789166 | CMS |
| Gilead Sciences, Inc. | $45.75 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133831949 | CMS |
| Gilead Sciences, Inc. | $480.00 | 08/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133600105 | CMS |
| Merck Sharp & Dohme LLC | $2,135.00 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141552984 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.